Pharmafile Logo
Pharmafocus logo
Advanced Search

National Institute of Allergy and Infectious Diseases

Showing 1 posts of 1 posts found.

shutterstock_gonnorrhea

Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2

November 8, 2018
Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin

A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025